Te­va de­nies big lay­offs are planned, but will push greater ef­fi­cien­cy and shut­ter floun­der­ing ef­forts

With its ex­ec­u­tive suite in tur­moil, its flag­ship drug un­der at­tack and its books bur­dened by debt fol­low­ing years of drought in its R&D arm …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA